News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Jay Z’s Shawn Carter Foundation in Collaboration with Coalition for Equity and Opportunity at Penn’s Wharton School, Launch ‘Champions for Financial Legacy’ Program for HBCUs
This partnership focuses on transforming Dr. Weigelt's community program, "Bridges to Wealth," into a broader initiative called "Champions for Financial Legacy."
Mitchell Lab Discovers Siloxane-Enhanced Nanoparticles and Refines LNPs to Advance mRNA Medicine
A group of researchers at Penn Engineering led by Michael Mitchell, PhD, Associate Professor in Bioengineering, have developed a method to direct lipid nanoparticles (LNPs) to target specific tissues.
Franklin Biolabs Names its First CEO
Franklin Biolabs, a Penn spinout founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, has named Vatsala Naageshwaran as its first chief executive officer.
Ocuphire Pharma Announces Acquisition of Opus Genetics, a Penn startup based on technology developed by Dr. Jean Bennett and colleagues
The merger between Opus and Ocuphire creates a transformative biotech company, renamed Opus Genetics, Inc, which is committed to the development of gene therapies for the treatment of IRDs.
EpiVario Secures Key Patents for Innovative Addiction Treatment
EpiVario, Inc., a Penn spinout co-founded by Shelley Berger, PhD, the Daniel S. Och University Professor at Penn Medicine, announced the issuance to Penn of US Patent No. 12,077,527.
Penn spinout REGENXBIO Presents Positive Data from Phase II Study for Wet AMD Treatment
Penn spinout REGENXBIO, co-founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, announced positive results from a phase II study for its treatment ABBV-RGX-314.
Interius BioTherapeutics Doses First Patient within vivo CAR T cell therapy
Interius has dosed its first patient in a clinical trial of its lead drug candidate, INT2104, an in vivoCAR T cell therapy that targets B-cell malignancies
Penn Spinout ViTToria Biotherapeutics Raises $25M
This funding is a $10 million extension to its previous $15 million financing secured in November 2023.
Heirloom Carbon Technologies Raises $150M Series B to Scale Direct Air Capture Technology
Heirloom's proprietary and cost-efficient technology enhances limestone’s natural ability to capture carbon dioxide.
Philadelphia Region’s Tech and Innovation Ecosystem Showcased in Technical.ly
Philadelphia has built a strong foundation for its innovation ecosystem.